Form 4: DSS, Inc. Reports Changes in Beneficial Ownership of Impact Biomedical Inc. Shares

DSS, Inc. reports transactions involving Impact Biomedical Inc. (IBO) common stock, indicating changes in beneficial ownership.

Summary

• DSS, Inc. filed a Form 4 detailing changes in their beneficial ownership of Impact Biomedical Inc. (IBO) common stock.
• On December 2, 2024, DSS, Inc. disposed of 20 shares of common stock at a price of $2.9.
• On March 20, 2025, DSS, Inc. acquired 200 shares of common stock at a price of $1.55.
• Also on March 20, 2025, DSS, Inc. disposed of 53,280 shares of common stock at a price of $4.68.
• The shares are indirectly owned through Sentinel Brokers Company, Inc., DSS BioHealth Security, Inc., DSS Securities, Inc., and DSS BlockChain Security, Inc.
• Following these transactions, DSS, Inc. continues to indirectly own shares through these entities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are a standard part of regulatory compliance for individuals and entities with significant ownership in publicly traded companies, providing transparency into their trading activities.

Key Dates

Keywords

beneficial ownership, Form 4, Impact Biomedical Inc., DSS, Inc., common stock, transactions, securities